期刊文献+
共找到196篇文章
< 1 2 10 >
每页显示 20 50 100
Design,delivery and efficacy testing of therapeutic nucleic acids used to inhibit hepatitis C virus gene expression in vitro and in vivo 被引量:9
1
作者 Wolfgang H.Caselmann Matthias Serwe +3 位作者 Thomas Lehmann János Ludwig Brian S.Sproat Joachim W.Engels 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第5期626-629,共4页
Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be ... Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be treated effectively.Toimprove this response rate we used antisensetechnologies to inhibit HCV translation as possibleadditional option for experimental treatment.Antisense oligodeoxynucleotides(ODN) are 展开更多
关键词 hepatitis C-like viruses/therapy gene expression in VITRO in vivo nucleic acids/therapeutic use CYTOMEGALOVIRUS
下载PDF
Therapeutic and Medicinal Uses of <i>Aloe vera</i>: A Review 被引量:5
2
作者 Pankaj K. Sahu Deen Dayal Giri +5 位作者 Ritu Singh Priyanka Pandey Sharmistha Gupta Atul Kumar Shrivastava Ajay Kumar Kapil Dev Pandey 《Pharmacology & Pharmacy》 2013年第8期599-610,共12页
The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, ... The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, minerals, enzymes, amino acids, natural sugars and other bioactive compounds with emollient, purgative, anti-microbial, anti inflammatory, antioxidant, aphrodisiac, anti-helmenthic, antifungal, antiseptic and cosmetic values for health care. This plant has potential to cure sunburns, burns and minor cuts, and even skin cancer. The external use in cosmetic primarily acts as skin healer and prevents injury of epithelial tissues, cures acne and gives a youthful glow to skin, also acts as extremely powerful laxative. 展开更多
关键词 ALOE vera Antimicrobial therapeutic MEDICINAL useS Cosmetic Application
下载PDF
Blastocystis hominis as a cause of chronic diarrhea in low-resource settings:A systematic review
3
作者 Stephen Amoak Jonathan Soldera 《World Journal of Meta-Analysis》 2024年第3期30-41,共12页
BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is... BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is particularly prevalent in developing nations.Examining the symptoms and treatment outcomes of B.hominis infection in low-resource settings holds immense significance,providing healthcare practi-tioners with valuable insights to enhance patient care.AIM To synthesize existing evidence on the symptomatology and treatment outcomes of B.hominis infection in low-resource settings.METHODS Following the Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines,a systematic review was conducted.The search spanned electronic databases including PubMed,Scopus,and Google Scholar.After a comprehensive screening process,a thorough examination of the papers,adhering to inclusion and exclusion criteria,and data extraction from eligible studies was conducted.The findings underwent summarization through simple descriptive analysis.RESULTS The search yielded 1200 papers,with 17 meeting inclusion criteria.Chronic diarrhea due to B.hominis infection was reported in only two studies,while abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting emerged as the most commonly documented symptoms.Recovery rates after one week of treatment ranged from 71.8%to 100%,and after two weeks,from 60%to 100%.CONCLUSION In low-resource settings,chronic diarrhea resulting from B.hominis infection is infrequent.Common symptoms include abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting.Post-treatment,clinical outcomes are notably favorable,supporting the recommendation for treatment.Metronidazole is advocated as the first-line agent,with consideration for switching to a second-line option in cases of treatment failure or poor response. 展开更多
关键词 Blastocystis infections Gastrointestinal diseases Treatment outcome Developing countries Metronidazole/therapeutic use
下载PDF
Continuous Wear of Hydrogel Contact Lenses for Therapeutic Use
4
作者 Daisuke Kudo Hiroshi Toshida +1 位作者 Toshihiko Ohta Akira Murakami 《Open Journal of Ophthalmology》 2012年第4期110-113,共4页
Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one w... Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one week of continuous therapeutic wear during 10 years. The reason for prescription of CLs, the primary disease, the duration of CL wear and the complications were assessed retrospectively. Results: The predominant reason for prescription of CLs was relief of pain or a foreign-body sensation (62.3%) and protection of the corneal epithelium (20.6%). The primary disease was post-penetrating keratoplasty (36.8%), followed by corneal epithelial erosion (14.5%), post-lamellar keratoplasty (14.0%) and bullous keratopathy (12.2%). The average duration of wearing single lens was 6.5 ± 3.2 days. The average duration of wearing CLs in total was 9.2 ± 10.7 months. The most frequent problem associated with continuous wear of CLs was their dropping out of CLs (12.3%). The complications associated with CLs included conjunctivitis with papillary hyperplasia, corneal erosion and superficial punctate keratitis, but corneal ulcer and corneal infiltrates were not found. Conclusion: Serious complications were not shown changing the lenses every week to keep to the prescribed time limit for continuous therapeutic wear, even if corneal epithelial barrier function is impaired. 展开更多
关键词 therapeutic use BANDAGE Soft Contact LENS CONTINUOUS WEAR COMPLICATION
下载PDF
Comparison of long-lasting therapeutic effects between succimer and penicillamine on hepatolenticular degeneration 被引量:3
5
作者 REN Ming Shan, ZHANG Zhi, WU Jun Xia, LI Fei, XUE Ben Chun and YANG Ren Min 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第6期75-77,共3页
AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. ... AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. Group A ( n =60) received Suc 750mg , po. bid. Group B ( n =60) received Pen 250mg , po. qid. The period of maintenance treatment varied from 6 months to 3 years, averaging 1 5 years. Symptoms and therapeutic effects were evaluated by modified Goldstein scale. RESULTS The total effectiveness of group A in two different periods of treatment were 80% and 85% respectively, higher than those of group B (58% and 59% respectively) ( P <0 05). Suc also had obvious curative effects for the patients who failed in the use of Pen. There were fewer side effect in group A than in group B ( P <0 05). Suc and Pen could increase urinary copper excretion effectively and continually. CONCLUSION Suc is more effective and safer than Pen. Clinically, it can replace Pen as first choice drug for long term maintenance therapy of HLD. 展开更多
关键词 hepatolenticular degeneration/drug THERAPY succimer/therapeutic use penicillamine/therapeutic use
下载PDF
Functional dyspepsia of ulcer-dysmotility type:clinical incidence and therapeutic strategy 被引量:3
6
作者 WANG XiaoZhong and LIN GuZhen 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第4期95-96,共2页
Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhe... Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhenSubjectheaadings... 展开更多
关键词 dyspepsia/drug therapy famotidine/therapeutic use cisapride/therapeutic use peptic ULCER gastrointestinal motility
下载PDF
Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract 被引量:5
7
作者 Tsunenori Kondo Toshio Takagi Kazunari Tanabe 《World Journal of Clinical Oncology》 CAS 2015年第6期237-251,共15页
Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional n... Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional nodes for tumors of the right renal pelvis or the right upper two-thirds of the ureter. A prospective study showed that an anatomical templatebased lymphadenectomy significantly improved patient survival in tumors of the renal pelvis. This benefit was more evident for patients with p T2 stage tumors or higher. The risk of regional node recurrence is significant reduced by template-based lymphadenectomy,which is likely to be associated with improved patient survival. The removal of lymph node micrometastases is assumed to be the reason for therapeutic benefit following lymphadenectomy. The number of resected lymph nodes can be used to assess the quality of lymphadenectomy,but not to determine the extent of lymphadenectomy. The guidelines currently recommend lymphadenectomy for patients with muscle-invasive disease,even though the current recommendation grades are still low. The present limitation of lymphadenectomy is the lack of standardization of the extent of lymphadenectomy and the randomized trials. Further studies are warranted to collect the evidence to support lymphadenectomy. 展开更多
关键词 LYMPHADENECTOMY LYMPH node EXCISION UROTHELIAL carcinoma Treatment outcome therapeutic uses Diagnosis GUIDELINE
下载PDF
Controversies regarding transplantation of mesenchymal stem cells
8
作者 Tsvetelina Velikova Tereza Dekova Dimitrina Georgieva Miteva 《World Journal of Transplantation》 2024年第2期48-61,共14页
Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intric... Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intricate landscape of MSC controversies,drawing upon 15 years of clinical experience and research.We delve into the fundamental properties of MSCs,exploring their unique immuno-modulatory capabilities and surface markers.The heart of our inquiry lies in the controversial applications of MSC transplantation,including the perennial debate between autologous and allogeneic sources,concerns about efficacy,and lingering safety apprehensions.Moreover,we unravel the enigmatic mechanisms surro-unding MSC transplantation,such as homing,integration,and the delicate balance between differentiation and paracrine effects.We also assess the current status of clinical trials and the ever-evolving regulatory landscape.As we peer into the future,we examine emerging trends,envisioning personalized medicine and innovative delivery methods.Our review provides a balanced and informed perspective on the controversies,offering readers a clear understanding of the complexities,challenges,and potential solutions in MSC transplantation. 展开更多
关键词 Mesenchymal stem cells Transplantation controversies Regenerative medicine Autoimmune diseases Chronic inflammatory illnesses Tumor growth METASTASIS therapeutic potential Clinical use of mesenchymal stem cell
下载PDF
白蛋白结合型紫杉醇联合顺铂治疗中晚期宫颈癌的效果分析
9
作者 陈坤燕 顾欣欣 《实用妇科内分泌电子杂志》 2024年第10期27-29,34,共4页
目的探讨晚期宫颈癌采用白蛋白结合型紫杉醇联合顺铂的治疗效果。方法选择98例中晚期宫颈癌患者为研究对象,根据随机数字表法分为研究组和对照组,每组49例。对照组采用紫杉醇结合顺铂治疗,研究组采用白蛋白结合型紫杉醇联合顺铂治疗,比... 目的探讨晚期宫颈癌采用白蛋白结合型紫杉醇联合顺铂的治疗效果。方法选择98例中晚期宫颈癌患者为研究对象,根据随机数字表法分为研究组和对照组,每组49例。对照组采用紫杉醇结合顺铂治疗,研究组采用白蛋白结合型紫杉醇联合顺铂治疗,比较两组血清肿瘤标志物水平、治疗效果及不良反应。结果治疗前,两组鳞状上皮细胞癌抗原(SCCA)、细胞角蛋白19的可溶性片段(CYFRA21-1)水平比较,差异均无统计学意义(P>0.05);治疗后,研究组SCCA、CYFRA21-1水平均低于对照组(P<0.05);研究组治疗总有效率高于对照组(P<0.05);研究组不良反应发生率低于对照组(P<0.05)。结论中晚期宫颈癌采用白蛋白结合型紫杉醇联合顺铂的治疗效果较好,可降低血清肿瘤标志物水平,减少不良反应发生率,值得临床推广与应用。 展开更多
关键词 宫颈癌 中晚期 白蛋白结合型紫杉醇 顺铂 治疗效果
下载PDF
Clinacanthus nutans:a review of the medicinal uses,pharmacology and phytochemistry 被引量:10
10
作者 Md.Ariful Alam Sahena Ferdosh +4 位作者 Kashif Ghafoor Md.Abdul Hakim Abdul Shukor Juraimi Alfi Khatib Md.Zaidul I.Sarker 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2016年第4期393-399,共7页
Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bite... Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bites,lesions caused by herpes simplex virus,diabetes,and gout in Malaysia.Indonesia.Thailand and China.Phylochemieal investigations documented the varied contents of bioaclive compounds from litis plant namely flavonoids,glycosides,glycoglyeerolipids.cerebrosides and monoacylmonogalatosylglycerol.The pharmacological experiment proved that various types of extracts and pure compounds from this species exhibited a broad range of biological properties such as anti-inflammatory,antiviral,antioxidant,and anti-diabetic activities.The lindings of toxicity study showed that extracts from this plant did not show any toxicity thus it can be used as strong therapeutic agents for specific diseased conditions.However,further experiments on chemical components and their mode of action showing biological activities are required to elucidate the complete phytochemical profile and assess to confirm their suitability tor future drugs.This review summarizes the medicinal uses,phytochemistry and pharmacology of this plant in order to explore its therapeutic potential and gaps necessitating for prospected research work. 展开更多
关键词 Clinacanthus nutans MEDICINAL useS PHYTOCHEMICALS PHARMACOLOGY therapeutic potential
下载PDF
Meta-analysis of efficacy and safety of Endostar combined with vinorelbine and cisplatin in the treatment of non-small cell lung cancer
11
作者 Ze-Yun Li Qing-Xia Lan +2 位作者 Cheng-Xin Liu Zhe Sun Yang Cao 《Journal of Hainan Medical University》 2022年第8期29-35,共7页
Objective:To systematically evaluate the efficacy and safety of rh-endostain(YH-16,Endostar)combined with vinorelbine and cisplatin(NP regimen)in the treatment of non-small cell lung cancer(NSCLC),and to provide evide... Objective:To systematically evaluate the efficacy and safety of rh-endostain(YH-16,Endostar)combined with vinorelbine and cisplatin(NP regimen)in the treatment of non-small cell lung cancer(NSCLC),and to provide evidence-based reference for clinical drug use.Methods:Retrieved from PubMed,EMBASE,the Cochrane Library,Clinical Trials,CNKI,VIP and Wan Fang database,randomized controlled trials(RCT)about YH-16 combined with NP regimen(NPY regimen,trial group)vs.NP regimen(control group)for NSCLC were collected.After screening the literature and extracting the data,the two persons evaluated the quality of the included studies,and used Rev Man 5.3 software to merge effect size.Results:A total of 18 articles were included,with a total of 2051 patients.Results of Meta-analysis showed that response rate[RR=1.66,95%CI(1.44,1.91),P<0.00001]、clinical benefit rate[RR=1.21,95%CI(1.14,1.29),P<0.00001]and quality of life improvement rate[RR=3.42,95%CI(2.45,4.79),P<0.00001]of trial group were significantly higher than those of control group.Besides,the serum CEA level[MD=-4.78,95%CI(-7.11,-2.46),P<0.0001]and CA125 level[MD=-16.44,95%CI(-20.83,-12.05),P<0.00001]of trial group were significantly lower than that of control group.There was no statistical significance in the 1-year survival rate and the incidence of myelosuppression,cardiotoxicity,gastrointestinal reaction,damage to the kidneys and liver,and alopecia(P>0.05).Conclusion:Compared with NP regimen alone,NPY regimen can improve the efficacy and quality of life of NSCLC patients,reduce the level of tumor markers,and does not increase the occurrence of adverse reactions,and has good efficacy and safety.However,the existing evidence shows that NPY regimen has the same effect as NP regimen alone in improving the 1-year survival rate of patients.The above conclusions need to be confirmed by further studies. 展开更多
关键词 Rh-endostain VINORELBINE cisplatin Non-small cell lung cancer therapeutic efficacy Safety META-ANALYSIS
下载PDF
High-intensity focused ultrasound extracorporeal ablation of liver tissuesin rabbits
12
《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第2期16-16,共1页
HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZ... HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZhaoYou1,YUYao1,B... 展开更多
关键词 LIVER neoplasms experimental/therapy ultrasonic THERAPY iodized oil/therapeutic use liver/radiation effects randomized controlled trials
下载PDF
The role of drug utilization evaluation in medical sciences
13
作者 Ruby Gangwar Arvind Kumar +2 位作者 Abrar Ahmed Zargar Amit Sharma Ranjeet Kumar 《Global Health Journal》 2023年第1期3-8,共6页
Background:Drug utilization evaluation(DUE)is defined by the World Health Organization(WHO)and focuses on the medical,social,and economic consequences of pharmaceutical marketing,distribution,prescribing,and usage in ... Background:Drug utilization evaluation(DUE)is defined by the World Health Organization(WHO)and focuses on the medical,social,and economic consequences of pharmaceutical marketing,distribution,prescribing,and usage in society.The WHO recommends a physician to every 1000 people.According to the recent data from the Health Ministry in 2019,in which 1.16 million doctors are of active population with just 80%,or 0.9 million,practicing.As a result,a ratio of 0.68 doctors for every 1000 people,which is much below as per the WHO reports.This article describes history,types,WHO guidelines,need and purpose of DUE.Objective:The main aim of this paper is to provide information about the rational use of medication in outpa­tient and inpatient department with special emphasis of DUEs.It also provides awareness directly to healthcare professionals,researchers,academicians,pharmacist and nurses to reduce the irrationality of medicines.Methods:The method used to compile this review information gathered from websites,Google scholar,PubMed,Research gate,and studies published on DUE from July 20 to Oct 22 were included as source of information.Results:We studied more than 35 published study on DUE,that reveals most of the physicians prescribed branded drugs not generic drugs,but WHO prescribing indicator allows to prescribe generic drugs in the hospital pharmacy to maintain better inventory control.It may also help to prevent pharmacist misunderstanding during dispensing.Conclusion:The use of generic prescription names avoids the possibility of medication product duplication and lowers patient costs.It is important to remember that incorrect medication prescriptions have impact on both patients and their family members.WHO indicators identify irrational prescribing behaviours to make therapy more rational and cost-effective. 展开更多
关键词 Anatomical therapeutic chemical classification Drug utilization evaluation Prescribing indicators Pregnancy risk classification Rational use of the drug
下载PDF
培美曲塞联合顺铂治疗非小细胞肺癌的临床效果及安全性分析
14
作者 张志蓉 买吐地·吾布来山 《中国实用医药》 2023年第14期99-102,共4页
目的分析非小细胞肺癌患者接受培美曲塞联合顺铂治疗的临床效果与安全性。方法52例接受放化疗治疗的非小细胞肺癌患者为研究对象,随机分为参照组与研究组,各26例。参照组应用顺铂治疗,研究组应用顺铂联合培美曲塞治疗。对比两组临床疗... 目的分析非小细胞肺癌患者接受培美曲塞联合顺铂治疗的临床效果与安全性。方法52例接受放化疗治疗的非小细胞肺癌患者为研究对象,随机分为参照组与研究组,各26例。参照组应用顺铂治疗,研究组应用顺铂联合培美曲塞治疗。对比两组临床疗效、毒副反应发生情况及治疗前后血清肿瘤标志物水平。结果研究组近期治疗总有效率84.62%和总控制率96.15%均高于参照组的53.85%、73.08%,差异有统计学意义(P<0.05)。治疗后,研究组癌胚抗原(CEA)(12.39±4.12)ng/ml、糖类抗原125(CA125)(46.56±5.26)U/ml、细胞角蛋白19(CK-19)(2.29±0.88)ng/ml均低于参照组的(16.96±4.36)ng/ml、(63.87±5.54)U/ml、(3.98±0.29)ng/ml,差异有统计学意义(P<0.05)。研究组肝功能异常、血小板减少、胃肠不适、贫血、白细胞减少、恶心呕吐发生率均低于参照组,差异均有统计学意义(P<0.05)。结论将培美曲塞联合顺铂应用于非小细胞肺癌的治疗中,对于降低肿瘤标志物水平,提高近期疗效,控制疾病进展有积极意义,而且毒副反应发生较少,安全性相对较高。 展开更多
关键词 培美曲塞 顺铂 非小细胞肺癌 治疗效果 安全性
下载PDF
USE OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL THERAPEUTICS
15
作者 Doo Suk Lee Min-Jung Bae Sunyoung Kim 《World Journal of Traditional Chinese Medicine》 2015年第4期91-91,共1页
The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of b... The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of biologically active molecules generates major difficulties associated with botanical therapeutics in general.This includes management of raw materials,poor understanding of 展开更多
关键词 use OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL therapeuticS PG
原文传递
吉西他滨联合顺铂治疗复发转移性膀胱癌的Ⅱ期临床研究 被引量:15
16
作者 洪卫 余新民 +5 位作者 郭勇 张沂平 钟海均 范云 冯建国 马胜林 《实用肿瘤杂志》 CAS 2008年第2期175-177,共3页
目的评价吉西他滨联合顺铂治疗晚期膀胱癌的疗效和安全性。方法32例Ⅳ期膀胱癌接受吉西他滨联合顺铂方案化疗:吉西他滨1200mg/m^2,第1天和第8天,顺铂25mg/m^2,第1-3天,21天为1个周期。结果32例患者中完全缓解4例,部分缓解13例,有效率为... 目的评价吉西他滨联合顺铂治疗晚期膀胱癌的疗效和安全性。方法32例Ⅳ期膀胱癌接受吉西他滨联合顺铂方案化疗:吉西他滨1200mg/m^2,第1天和第8天,顺铂25mg/m^2,第1-3天,21天为1个周期。结果32例患者中完全缓解4例,部分缓解13例,有效率为53.1%,中位肿瘤进展时间(TTP)8.5个月,中位生存时间为14个月,1年生存率58.3%。毒性反应主要为血液学毒性、消化道反应。结论吉西他滨联合顺铂3周方案是治疗晚期膀胱癌安全、有效的化疗方案。 展开更多
关键词 膀胱肿瘤/药物疗法 吉西他滨/治疗应用 顺铂/治疗应用
下载PDF
Geldanamycin增强顺铂的抗肿瘤作用 被引量:25
17
作者 廖志勇 张胜华 甄永苏 《癌症》 SCIE CAS CSCD 北大核心 2000年第8期731-734,共4页
研究抗生素苯醌安莎霉素(Geldanamycin ,GDM)对人肝癌BEL 7402细胞周期的影响和联合应用顺铂 (CDDP)的体外体内抗肿瘤作用。方法 :采用MTT法检测药物的生长抑制作用 ,[3H] TdR掺入法测定DNA合成抑制作用 ,流式细胞术分析细胞周期 ,小鼠... 研究抗生素苯醌安莎霉素(Geldanamycin ,GDM)对人肝癌BEL 7402细胞周期的影响和联合应用顺铂 (CDDP)的体外体内抗肿瘤作用。方法 :采用MTT法检测药物的生长抑制作用 ,[3H] TdR掺入法测定DNA合成抑制作用 ,流式细胞术分析细胞周期 ,小鼠移植性肝癌H22模型研究药物单用或联合应用时的体内抗肿瘤作用。结果 :MTT法测得GDM对BEL 7402细胞的生长抑制IC50为0 28μmol/L。GDM处理BEL 7402细胞4h ,抑制DNA合成的IC50为14μmol/L。1 0、10μmol/LGDM处理BEL 7402细胞24h后S期细胞比例明显下降 ,并持续到48h ;0 1、1 0、10μmol/L的GDM引起G2/M期的明显阻断 ,24h时达高峰值 ,48h后开始回复。体外0 1μmol/L和0 2μmol/LGDM均增强CDDP对BEL 7402细胞的细胞毒作用。小鼠移植肝癌H22模型中 ,单用1 5mg/kgCDDP组两批试验的抑瘤率均为73 % ,顺铂联用0 38mg/kgGDM两批试验的抑瘤率分别为89 %和82% ,两者有显著性差异(P<0 05) ,其CDI值分别为0 41和0 72。结论 展开更多
关键词 GELDANAMYCIN 顺铂 肿瘤 药物疗法
下载PDF
甘氨双唑钠联合小剂量顺铂对中晚期食管癌放疗的增敏作用 被引量:6
18
作者 廖小方 周正仕 +6 位作者 郑勤红 胡慧 朱小平 何慧娟 胡伟 王燕 余文亮 《实用肿瘤杂志》 CAS 北大核心 2010年第5期569-572,共4页
目的探讨甘氨双唑钠联合小剂量顺铂对中晚期食管癌同期放疗的增敏作用并评估其应用前景。方法 62例中晚期食管癌患者全部采用三维适形放射治疗,总剂量60~70 Gy。所有患者被先后随机地(机械抽样法)分成A、B两组。A组:顺铂每天10 mg,... 目的探讨甘氨双唑钠联合小剂量顺铂对中晚期食管癌同期放疗的增敏作用并评估其应用前景。方法 62例中晚期食管癌患者全部采用三维适形放射治疗,总剂量60~70 Gy。所有患者被先后随机地(机械抽样法)分成A、B两组。A组:顺铂每天10 mg,连续静脉滴注5天,周一至周五;应用甘氨双唑钠700 mg/m2于放疗前静脉滴注,每周3次,用药后1小时内接受放疗。B组:为对照组,仅应用甘氨双唑钠700 mg/m2于放疗前静脉滴注,每周3次,用药后1小时内接受放疗。结果治疗结束后1月进行疗效评价,甘氨双唑钠联合小剂量顺铂总有效率为93.3%;对照组总有效率为70.0%,两组比较差异有统计学意义(P〈0.05)。结论甘氨双唑钠联合小剂量顺铂放疗增敏能提高中晚期食管癌的放疗效果,且较单用甘氨双唑钠放疗增敏效果好。 展开更多
关键词 食管肿瘤 放射疗法 甘氨双唑钠/治疗应用 顺铂/治疗应用
下载PDF
多西他赛联合奈达铂和顺铂治疗晚期非小细胞肺癌临床观察 被引量:13
19
作者 陈雷 陈建章 +1 位作者 尤传文 刘金平 《实用肿瘤杂志》 CAS 2012年第1期77-79,共3页
目的观察多西他赛联合双铂方案治疗晚期非小细胞肺癌的近期疗效及不良反应。方法 60例患者随机分为治疗组和对照组,每组30例。治疗组:多西他赛75 mg/m2,分别于第1、8天给药;顺铂(PDD)15 mg/(m2.d),d1-3天;奈达铂(NDP)50 mg/m2,d5;对照组... 目的观察多西他赛联合双铂方案治疗晚期非小细胞肺癌的近期疗效及不良反应。方法 60例患者随机分为治疗组和对照组,每组30例。治疗组:多西他赛75 mg/m2,分别于第1、8天给药;顺铂(PDD)15 mg/(m2.d),d1-3天;奈达铂(NDP)50 mg/m2,d5;对照组:多西他赛75 mg/m2,分别于第1、8天给药;顺铂(PDD)25mg/(m2.d),d1-3天。21天为1周期。结果治疗组:CR 2例,PR 12例,SD 15例,PD 1例,有效率(RR)为46.7%(14/30);对照组:CR 1例,PR 12例,SD 15例,PD 2例,有效率(RR)43.3%(13/30),两组有效率比较差异无统计学意义(P>0.05);对照组呕吐的发生率明显高于治疗组(P<0.05)。白细胞减少治疗组为96.7%,对照组为93.3%(P>0.05)。血小板减少治疗组为73.3%,对照组为30.0%(P<0.05)。结论多西他赛联合双铂方案治疗晚期非小细胞肺癌的疗效确切,不良反应可耐受。 展开更多
关键词 非小细胞肺 药物疗法 多西他赛/治疗应用 顺铂/治疗应用 奈达铂/治疗应用 不良反应
下载PDF
多西他赛和顺铂同步放化疗治疗局部晚期鼻咽癌临床观察 被引量:10
20
作者 陈建章 尤传文 +1 位作者 刘金平 陈雷 《实用肿瘤杂志》 CAS 北大核心 2011年第2期191-194,共4页
目的观察局部晚期鼻咽癌同步放化疗的疗效及毒副反应。方法 70例局部晚期鼻咽癌,采用静脉化疗2周期,化疗方案:多西他赛75 mg/m2,分于第1,8天给药;顺铂(DDP)25 mg/(m2.d)d1-3天,21天为1周期。同时给予同步放疗,鼻咽部原发灶给予6 MV-X线... 目的观察局部晚期鼻咽癌同步放化疗的疗效及毒副反应。方法 70例局部晚期鼻咽癌,采用静脉化疗2周期,化疗方案:多西他赛75 mg/m2,分于第1,8天给药;顺铂(DDP)25 mg/(m2.d)d1-3天,21天为1周期。同时给予同步放疗,鼻咽部原发灶给予6 MV-X线和15 MV-X线DT 70 Gy^78 Gy/7-8周。结果 70例中CR 20例,PR 37例,总有效率81.4%。1年、3年生存率分别为98.4%、83.9%。主要毒副反应为骨髓抑制、急性口腔黏膜炎、恶心呕吐、皮肤反应。结论多西他赛和顺铂同步放化疗治疗局部晚期鼻咽癌疗效较好,毒副反应可以耐受。 展开更多
关键词 鼻咽肿瘤/药物疗法 鼻咽肿瘤/放射疗法 紫杉烷类/治疗应用 紫杉烷类/副作用 顺铂/治疗应用 顺铂/副作用 综合疗法
下载PDF
上一页 1 2 10 下一页 到第
使用帮助 返回顶部